Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
CNY 4.11
(2.49%)
CNY 4.11
(2.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -98.97 Million CNY | -485.66% |
| 2022 | 25.66 Million CNY | 134.18% |
| 2021 | -75.09 Million CNY | 70.16% |
| 2020 | -251.67 Million CNY | 54.13% |
| 2019 | -548.63 Million CNY | -6.79% |
| 2018 | -513.73 Million CNY | -45.69% |
| 2017 | -352.62 Million CNY | -58.3% |
| 2016 | -222.74 Million CNY | -110.89% |
| 2015 | -105.62 Million CNY | 86.13% |
| 2014 | -761.44 Million CNY | 5.31% |
| 2013 | -804.14 Million CNY | 20.98% |
| 2012 | -1.01 Billion CNY | 13.17% |
| 2011 | -1.17 Billion CNY | -5351.52% |
| 2010 | -21.49 Million CNY | -410.44% |
| 2009 | 6.92 Million CNY | 193.78% |
| 2008 | -7.38 Million CNY | -332.25% |
| 2007 | 3.17 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -236.52 Million CNY | -5.39% |
| 2024 Q3 | -406.59 Million CNY | -71.34% |
| 2024 Q1 | -224.42 Million CNY | -126.74% |
| 2023 Q1 | 140.91 Million CNY | 449.04% |
| 2023 Q4 | -98.97 Million CNY | -200.99% |
| 2023 FY | -98.97 Million CNY | -485.66% |
| 2023 Q2 | 139.73 Million CNY | -0.84% |
| 2023 Q3 | 98 Million CNY | -29.86% |
| 2022 Q3 | 65.81 Million CNY | -58.78% |
| 2022 FY | 25.66 Million CNY | 134.18% |
| 2022 Q2 | 159.69 Million CNY | 505.0% |
| 2022 Q4 | 25.66 Million CNY | -61.01% |
| 2022 Q1 | -39.43 Million CNY | 47.49% |
| 2021 Q3 | -15.56 Million CNY | -131.66% |
| 2021 FY | -75.09 Million CNY | 70.16% |
| 2021 Q1 | -117.31 Million CNY | 53.39% |
| 2021 Q2 | 49.14 Million CNY | 141.89% |
| 2021 Q4 | -75.09 Million CNY | -382.58% |
| 2020 Q3 | -219.83 Million CNY | 13.81% |
| 2020 Q4 | -251.67 Million CNY | -14.48% |
| 2020 Q2 | -255.06 Million CNY | 31.7% |
| 2020 Q1 | -373.43 Million CNY | 31.93% |
| 2020 FY | -251.67 Million CNY | 54.13% |
| 2019 Q2 | -581.29 Million CNY | -7.56% |
| 2019 Q4 | -548.63 Million CNY | -4.08% |
| 2019 FY | -548.63 Million CNY | -6.79% |
| 2019 Q3 | -527.11 Million CNY | 9.32% |
| 2019 Q1 | -540.45 Million CNY | -5.2% |
| 2018 Q3 | -478.41 Million CNY | -37.48% |
| 2018 Q1 | -221.87 Million CNY | 37.08% |
| 2018 FY | -513.73 Million CNY | -45.69% |
| 2018 Q4 | -513.73 Million CNY | -7.38% |
| 2018 Q2 | -347.99 Million CNY | -56.84% |
| 2017 Q3 | -195.96 Million CNY | -14.7% |
| 2017 Q4 | -352.62 Million CNY | -79.94% |
| 2017 FY | -352.62 Million CNY | -58.3% |
| 2017 Q1 | -225.25 Million CNY | -1.12% |
| 2017 Q2 | -170.85 Million CNY | 24.15% |
| 2016 Q2 | 116.43 Million CNY | 133.88% |
| 2016 FY | -222.74 Million CNY | -110.89% |
| 2016 Q4 | -222.74 Million CNY | 9.77% |
| 2016 Q3 | -246.86 Million CNY | -312.01% |
| 2016 Q1 | -343.64 Million CNY | -225.35% |
| 2015 Q3 | -64.56 Million CNY | 28.67% |
| 2015 Q4 | -105.62 Million CNY | -63.6% |
| 2015 FY | -105.62 Million CNY | 86.13% |
| 2015 Q1 | -458.27 Million CNY | 39.82% |
| 2015 Q2 | -90.51 Million CNY | 80.25% |
| 2014 Q4 | -761.44 Million CNY | 0.5% |
| 2014 Q3 | -765.23 Million CNY | -1.97% |
| 2014 FY | -761.44 Million CNY | 5.31% |
| 2014 Q2 | -750.47 Million CNY | 7.93% |
| 2014 Q1 | -815.09 Million CNY | -1.36% |
| 2013 Q2 | -941.49 Million CNY | 4.23% |
| 2013 Q4 | -804.14 Million CNY | -1.63% |
| 2013 FY | -804.14 Million CNY | 20.98% |
| 2013 Q1 | -983.06 Million CNY | 3.39% |
| 2013 Q3 | -791.25 Million CNY | 15.96% |
| 2012 FY | -1.01 Billion CNY | 13.17% |
| 2012 Q1 | -1.1 Billion CNY | 5.56% |
| 2012 Q4 | -1.01 Billion CNY | 1.97% |
| 2012 Q3 | -1.03 Billion CNY | 3.73% |
| 2012 Q2 | -1.07 Billion CNY | 2.58% |
| 2011 Q1 | -1.34 Billion CNY | -6139.75% |
| 2011 FY | -1.17 Billion CNY | -5351.52% |
| 2011 Q4 | -1.17 Billion CNY | 5.16% |
| 2011 Q2 | -1.27 Billion CNY | 4.66% |
| 2011 Q3 | -1.23 Billion CNY | 3.37% |
| 2010 Q4 | -21.49 Million CNY | 0.0% |
| 2010 Q2 | -23.99 Million CNY | 0.0% |
| 2010 FY | -21.49 Million CNY | -410.44% |
| 2009 FY | 6.92 Million CNY | 193.78% |
| 2008 FY | -7.38 Million CNY | -332.25% |
| 2007 FY | 3.17 Million CNY | 0.0% |